highperformr logo

AB Science's Overview

Total employees12
HeadquartersParis
Founded

AB Science is a dynamic pharmaceutical company dedicated to discovering, developing, and commercializing innovative protein kinase inhibitors (PKIs). These targeted therapies are designed to address unmet medical needs in human health, particularly in oncology, inflammatory diseases, and central nervous system disorders, as well as in veterinary medicine. The company's lead compound, masitinib, has shown promise in various indications. AB Science focuses on a science-driven approach to bring novel treatments to patients and animals worldwide.

Where is AB Science's Headquarters?

AB Science officeAB Science officeAB Science officeAB Science office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as the central hub for AB Science's global operations, including strategic management, research and development oversight, corporate finance, and investor relations.

Notable Features:

Located in the prestigious 8th arrondissement of Paris, known for its proximity to major business centers and landmarks. The office space is designed to support advanced research coordination and corporate activities within a classic Parisian architectural setting.

Work Culture:

Characterized by a strong focus on scientific innovation, rigorous research methodologies, collaboration, and a commitment to advancing medical treatments. The environment fosters expertise and dedication among its highly specialized team.

HQ Significance:

The Paris headquarters is pivotal for AB Science, anchoring its French origins and its position within the European pharmaceutical landscape. It facilitates strategic decision-making, R&D direction, and engagement with European regulatory bodies and research institutions.

Values Reflected in HQ: The choice of a central, reputable Parisian address reflects the company's commitment to excellence, professionalism, and its strong French identity within the global pharmaceutical sector. It also positions them advantageously for attracting talent and fostering collaborations.

Location:

AB Science operates with a global outlook, managed from its Paris headquarters and supported by its U.S. subsidiary in New Jersey. The company's primary global footprint is through its extensive clinical trial programs, which are conducted across numerous countries in Europe, North America, and other key regions. This involves collaboration with international research institutions, hospitals, and contract research organizations (CROs) to advance its portfolio of protein kinase inhibitors for both human and veterinary applications worldwide.

Street Address:

3 Avenue George V

City:

Paris

State/Province:

Île-de-France

Country:

France

AB Science's Global Presence

Morristown, New Jersey, USA

Address: 55 Madison Avenue, Suite 400, Morristown, NJ 07960, USA (AB Science USA, L.L.C.)

To facilitate the progression of clinical trials in North America, engage with U.S. regulatory authorities, and explore strategic partnerships and commercialization opportunities in the region.

Buying Intent Signals for AB Science

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of AB Science

As of April 2025, AB Science' leadership includes:

Alain Moussy - Co-founder, Chairman and Chief Executive Officer
Laurent Guy - Chief Financial Officer
Prof. Olivier Hermine - President of the Scientific Committee

Investors of AB Science

AB Science has been backed by several prominent investors over the years, including:

Publicly Traded on Euronext Paris (Ticker: AB)
Founders and Management (including Alain Moussy as a significant shareholder)
Various institutional and individual shareholders via public stock market

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

No major publicly announced new hires or exits within the core executive team (e.g., CEO, CFO) of AB Science have been identified in the last 12 months (June 2023 - June 2024). The company's senior leadership has shown considerable stability.

Technology (Tech Stack) used by AB Science

Discover the tools AB Science uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

AB Science Email Formats and Examples

AB Science likely utilizes common corporate email formats. A frequently observed pattern for companies of this nature is the first initial followed by the last name, or first name separated by a dot from the last name. General inquiries can usually be directed to a generic contact email.

f[last]@ab-science.com (e.g., jdoe@ab-science.com) or [first].[last]@ab-science.com (e.g., jane.doe@ab-science.com). The general contact email is contact@ab-science.com.

Format

amoussy@ab-science.com (example based on a common format for Alain Moussy)

Example

75%

Success rate

News and media

AB Science Press ReleaseMay 28, 2024

AB Science Announces Positive Topline Results from Phase III Study of Masitinib in Progressive Multiple Sclerosis

AB Science reported that its Phase III study (AB21004) assessing masitinib in patients with primary progressive multiple sclerosis (PPMS) and non-active secondary progressive multiple sclerosis (nSPMS) successfully met its primary endpoint, demonstrating a statistically significant reduction in disability progression as measured by EDSS....more

AB Science Press ReleaseApril 26, 2024

AB Science Reports 2023 Full-Year Financial Results and Business Update

AB Science released its financial results for the full year 2023, detailing operating expenses of €13.6 million, a net loss of €14.0 million, and a cash position of €6.0 million. The company also provided updates on its ongoing clinical development programs for masitinib....more

AB Science Press ReleaseDecember 19, 2023

AB Science Announces Positive Phase 3 Study Results for Masitinib in Metastatic Castrate Resistant Prostate Cancer

The company announced positive outcomes from its confirmatory Phase 3 study (AB15003), indicating that masitinib in combination with docetaxel significantly improved overall survival by 4.9 months versus placebo plus docetaxel in patients with metastatic castrate resistant prostate cancer (mCRPC) eligible for docetaxel....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including AB Science, are just a search away.